<i>Smad4</i> Deficiency Promotes Pancreatic Cancer Immunogenicity by Activating the Cancer‐Autonomous DNA‐Sensing Signaling Axis-Reference-Cited by-同舟云学术

Smad4 Deficiency Promotes Pancreatic Cancer Immunogenicity by Activating the Cancer‐Autonomous DNA‐Sensing Signaling Axis

Published:2022-01-22 Issue:7 Volume:9 Page:2103029
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Xiong Wenjing¹,He Wenzhuo¹²,Wang Tiantian¹,He Shuai¹,Xu Feifei¹,Wang Zining¹,Wang Xiaojuan¹,Guo Hui¹,Ling Jianhua³,Zhang Huanling¹,Liu Yongxiang¹,Xing Kaili¹⁴,Li Mengyun¹,Zhang Hongxia¹,Li Jiahui⁵,Niu Ningning⁶,Xue Jing⁶,Zhan Qiuyao¹,Liu Ze‐Xian¹,Bei Jin‐Xin¹,Huang Peng¹,Liu Jinyun¹,Xia Liangping¹²,Xia Xiaojun¹^ORCID

Affiliation:

1. State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Sun Yat‐sen University Cancer Center Guangzhou 510060 China

2. VIP Region Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. China

3. Department of Molecular and Cellular Oncology The University of Texas MD Anderson Cancer Center Houston TX 77030 USA

4. Department of Pancreatobiliary Surgery Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. China

5. College of Food Science and Engineering Dalian Polytechnic University Liaoning 116034 P. R. China

6. State Key Laboratory of Oncogenes and Related Genes Stem Cell Research Center Ren Ji Hospital Shanghai Jiao Tong University School of Medicine Shanghai 200127 P. R. China

Funder

National Natural Science Foundation of China

Fundamental Research Funds for the Central Universities

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202103029

Reference69 articles.

1. Therapeutic developments in pancreatic cancer: current and future perspectives

2. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

3. A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors

4. Whole genomes redefine the mutational landscape of pancreatic cancer

5. DPC4 , A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual targeting chimeric antigen receptor cells enhance antitumour activity by overcoming T cell exhaustion in pancreatic cancer;British Journal of Pharmacology;2024-08-11

2. Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer;Molecular Cancer;2024-07-09

3. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma;Cell Death Discovery;2024-05-24

4. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

5. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer;Current Issues in Molecular Biology;2024-03-23